After an investigation into the manufacturing plant, federal regulators decided to discard millions of doses of the Johnson & Johnson vaccine.
Federal regulators are forcing Johnson & Johnson to scrap about 60 million doses of Covid-19 vaccine produced at a troubled Baltimore plant run by Emergent BioSolutions due to possible contamination, the New York Times reported Friday, citing people familiar with the matter. The plant was shuttered in April after an inspection revealed several violations, including possible contamination of J&J’s vaccines with a key ingredient from AstraZeneca’s Covid vaccine. About 170 million doses of both vaccines were in question after the inspection, the Times reported. The FDA confirmed to CNBC that several batches weren’t « suitable for use, » without confirming the exact number of doses that were discarded. It said it was clearing two batches of vaccine materials manufactured at the plant for use, according to an emailed statement.
